Therapeutic Anti-KIR Antibody of 1–7F9 Attenuates the Antitumor Effects of Expanded and Activated Human Primary Natural Killer Cells on In Vitro Glioblastoma-like Cells and Orthotopic Tumors Derived Therefrom

Glioblastoma (GBM) is the leading malignant intracranial tumor, where prognosis for which has remained extremely poor for two decades. Immunotherapy has recently drawn attention as a cancer treatment, including for GBM. Natural killer (NK) cells are immune cells that attack cancer cells directly and...

Descripción completa

Detalles Bibliográficos
Autores principales: Maeoka, Ryosuke, Nakazawa, Tsutomu, Matsuda, Ryosuke, Morimoto, Takayuki, Shida, Yoichi, Yamada, Shuichi, Nishimura, Fumihiko, Nakamura, Mitsutoshi, Nakagawa, Ichiro, Park, Young-Soo, Tsujimura, Takahiro, Nakase, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531877/
https://www.ncbi.nlm.nih.gov/pubmed/37762486
http://dx.doi.org/10.3390/ijms241814183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531877/
https://www.ncbi.nlm.nih.gov/pubmed/37762486
http://dx.doi.org/10.3390/ijms241814183

Ejemplares similares